BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12447813)

  • 1. [Prevention of fragile X syndrome by prenatal genetic diagnosis: advantages and controversial aspects].
    Tejada MI
    Rev Neurol; 2001 Oct; 33 Suppl 1():S14-9. PubMed ID: 12447813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of fragile X syndrome].
    Glover G; Bernabé MJ; Carbonell P
    Rev Neurol; 2001 Oct; 33 Suppl 1():S6-9. PubMed ID: 12447811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of the absence of FMR1 expression in full mutation chorionic villi.
    Willemsen R; Bontekoe CJ; Severijnen LA; Oostra BA
    Hum Genet; 2002 Jun; 110(6):601-5. PubMed ID: 12107447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X syndrome and fragile XE mental retardation.
    Sutherland GR; Mulley JC
    Prenat Diagn; 1996 Dec; 16(13):1199-211. PubMed ID: 9061751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of 53 fragile X families with the probe StB12.3.
    Puissant H; Malinge MC; Larget-Piet A; Martin D; Chauveau P; Odent S; Plessis G; Parent P; Lemarec B; Larget-Piet L
    Am J Med Genet; 1994 Dec; 53(4):370-3. PubMed ID: 7864047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preimplantation genetic diagnosis for fragile X syndrome: is there increased transmission of abnormal FMR1 alleles among female heterozygotes?
    Reches A; Malcov M; Ben-Yosef D; Azem F; Amit A; Yaron Y
    Prenat Diagn; 2009 Jan; 29(1):57-61. PubMed ID: 19097038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CGG variation through 642 meioses in Fragile X families.
    Rifé M; Badenas C; Quintó L; Puigoriol E; Tazón B; Rodriguez-Revenga L; Jiménez L; Sánchez A; Milà M
    Mol Hum Reprod; 2004 Oct; 10(10):773-6. PubMed ID: 15322225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
    Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
    Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of fragile X syndrome among selected patients at Songklanagarind Hospital during 1991-1996, studied by cytogenetic and molecular methods.
    Jinorose U; Vasiknanonte P; Limprasert P; Brown WT; Panich V
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():69-74. PubMed ID: 9640603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic tests for fragile X syndrome.
    Oostra BA; Willemsen R
    Expert Rev Mol Diagn; 2001 Jul; 1(2):226-32. PubMed ID: 11901818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach.
    Sofocleous C; Kitsiou S; Fryssira H; Kolialexi A; Kalaitzidaki M; Roma E; Tsangaris GT; Chistofidou C; Metaxotou C; Kanavakis E; Mavrou A
    In Vivo; 2008; 22(4):451-5. PubMed ID: 18712171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.